Skip to content
Screener

MiMedx Group MDXG EBITDA margin

EBITDA margin at other companies

IAR
Integra LifeSciencesIART
12.8%+7.9pp
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
6.1%-10.0pp
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
-4.4%
Solventum logo
SolventumSOLV
31.1%+15.4pp
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
11.9%+3.3pp
CorMedix logo
CorMedixCRMD
54.6%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Calculated from MiMedx Group’s reported figures.

Based on trailing twelve months.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071

FAQ

What is MiMedx Group's EBITDA margin?
MiMedx Group (MDXG) reported EBITDA margin of 4.7% in Q2 2026.
How has MiMedx Group's EBITDA margin changed year-over-year?
MiMedx Group's EBITDA margin decreased by 67.7% year-over-year, from 14.7% to 4.7%.
What is the long-term trend for MiMedx Group's EBITDA margin?
Over 4 years (2020 to 2025), MiMedx Group's EBITDA margin has grown at a 4.9% compound annual growth rate (CAGR), from -15.5% to 18.8%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about MiMedx Group's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude